(Q33897116)

English

Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Shinpo K

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kikuchi S

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sasaki H

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Ogata A

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Moriwaka F

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Tashiro K

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

861

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

151-159

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Amyotrophic lateral sclerosis. Insights from genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superox

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

The role of the Maillard reaction in other pathologies: Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement of glycation in motoneuron diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

The endogenous antioxidant glutathione as a factor in the survival of physically injured mammalian spinal cord neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Early contribution of oxidative glycation in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902047-3

7 January 2021

Identifiers

10.1016/S0006-8993(00)02047-3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33897116&oldid=1629150760"